Emily Hayes[email protected]Lung CancerOncologists urge faster biomarker results for lung cancer patientsOut of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker test results back in from one to two weeks, but while 63% reported that they get results in this time frame, 37% said that from three to four weeks was the average.June 8, 2021Molecular DiagnosticsEndometrial cancer patients may benefit from multigene testingThe data are strong enough to support routine testing, researchers reported at the meeting, which is being held in a virtual format from June 4-8.June 6, 2021Breast CancerLiquid biopsy enhances MRI studies of breast cancer patientsMeasuring plasma cell-free DNA (cfDNA) in patients after chemotherapy and prior to surgery has the potential to improve the accuracy of MRI alone in patients treated for localized breast cancer, according to the study, which was reported as a late-breaking presentation and featured in the press program at the virtual meeting.April 10, 2021Medical Imaging5 reasons lab professionals should get up to speed on TwitterTwitter has become a crucial social media hub for doctors and other healthcare professionals, as well as for media professionals following and publicizing medical research.#CAPVirtualPath has more than 9 million impressions! Bravo to @Pathologists and all the people making this possible. I love the composite image. #WeAreNotAlone#ILookLikeAPathologist pic.twitter.com/dtu2bxPx8YMarch 29, 2021GuidelinePatients approve of medical screening at dental officesIn the survey of 573 people, 89% were willing to have their dentist take their blood pressure and 82.9% were willing to undergo lab investigations for medical conditions, researchers from Saudi Arabia reported in a paper published February 2 in the open-access journal Dovepress.February 4, 2021COVID-19One year later, lab specialists reflect on life in the shadow of COVID-19The earliest stories in LabPulse.com about SARS-CoV-2 included a news item on January 17 about the publication of the full genome of the novel coronavirus and screening of air travelers coming in from Wuhan, per guidance from the U.S. Centers for Disease Prevention and Control (CDC).February 2, 2021510(k)CMS rejects Epi proColon payments, sets standards for cancer blood testsThe Epi proColon product screens for the presence in the blood of methylated septin 9 (mSEPT9) DNA; it is the only blood test cleared by the U.S. Food and Drug Administration (FDA) for colon cancer screening.January 20, 2021Lung CancerFalling lung cancer rates drive cancer decline in U.S. over past 2 decadesThe report found that in 2020, the cancer death rate was down by 31% compared with 1991, including a 2.4% decrease between 2017 and 2018, the ACS reported. The findings are in line with prior reports showing cancer death rates overall dropping in recent years.January 11, 2021CollaborationCOVID-19 pandemic accelerates adoption of diagnostic testing at point of carePoint-of-care testing has experienced a lasting shift that has the potential to expand access to diagnostics globally. Diagnostics entered the limelight in 2020, taking their rightful place at the center of the current and future healthcare systems, said Steve Dickman, CEO of life sciences consulting firm CBT Advisors, during an on-demand panel session at the Biotech Showcase, which is held annually in parallel with the J.P. Morgan Healthcare Conference.January 10, 2021InflammationInflammatory biomarkers help quickly size up COVID-19 patientsPoster studies are available on demand at the virtual meeting, which runs from December 13-17.December 16, 2020Page 1 of 2Next PageTop StoriesValidationImmunovia announces positive results for next-gen pancreatic cancer testDiagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.CollaborationVertex to pay $25M upfront to scale cell manufacturing technologyFinancial ResultsBristol Myers Squibb to reduce workforce in restructuring planLawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitSponsor ContentVisit our Molecular Diagnostics Community
